• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预后相关特征预测免疫疗法对肾透明细胞癌的疗效。

Prognostic related signature predicts the benefits of immunotherapy for kidney renal clear cell carcinoma.

作者信息

Xiong Feng, Wang Bowen, Zhang Haoxun, Zhang Guoling, Tao Boju, Liu Yiwen, Wang Chunyang

机构信息

Department of Urology Surgery, The First Affiliated Hospital of Harbin Medical University, Youzheng Street #23, Harbin, China.

出版信息

Discov Oncol. 2025 Jun 19;16(1):1153. doi: 10.1007/s12672-025-02991-5.

DOI:10.1007/s12672-025-02991-5
PMID:40536581
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12179015/
Abstract

Clear cell renal cell carcinoma (ccRCC) stands as the pivotal pathological subtype of renal cell carcinoma. However, there exists a dearth of pertinent biological targets crucial for advancing the clinical application of ccRCC. In our investigation, we employed the weighted gene co-expression network analysis (WGCNA) to discern 13 distinct gene co-expression modules, with the yellow module exhibiting a pronounced association with tumorigenesis. Concurrently, we scrutinized 6147 differentially expressed genes through rigorous differential expression analysis. Through an intersecting approach with the genes within the yellow module, we pinpointed 265 cancer-related genes displaying notable differential expression. Subsequent Cox-regression analysis unveiled that among the 265 genes, four were notably linked to ccRCC prognosis. Furthermore, we executed single-sample gene set enrichment analysis (ssGSEA) on the signature comprising these four genes, subsequently deriving normalized enrichment scores (NESs). This investigation substantiated that the said signature bears significant implications for prognosis, holding the potential to forecast the efficacy of immunotherapy.

摘要

透明细胞肾细胞癌(ccRCC)是肾细胞癌的关键病理亚型。然而,对于推进ccRCC临床应用至关重要的相关生物学靶点却十分匮乏。在我们的研究中,我们运用加权基因共表达网络分析(WGCNA)来识别13个不同的基因共表达模块,其中黄色模块与肿瘤发生呈现出显著关联。同时,我们通过严格的差异表达分析对6147个差异表达基因进行了仔细研究。通过与黄色模块内的基因进行交叉分析,我们确定了265个显示出显著差异表达的癌症相关基因。随后的Cox回归分析表明,在这265个基因中,有四个与ccRCC预后显著相关。此外,我们对包含这四个基因的特征进行了单样本基因集富集分析(ssGSEA),随后得出标准化富集分数(NESs)。这项研究证实,上述特征对预后具有重要意义,具有预测免疫治疗疗效的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddc9/12179015/bf04f5e56897/12672_2025_2991_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddc9/12179015/6a60b1b6fbe1/12672_2025_2991_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddc9/12179015/669dce09fca8/12672_2025_2991_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddc9/12179015/32412dc0c88e/12672_2025_2991_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddc9/12179015/0545f4f5a7a1/12672_2025_2991_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddc9/12179015/82fb6c6743b2/12672_2025_2991_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddc9/12179015/147aa841543f/12672_2025_2991_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddc9/12179015/22be81cae3cb/12672_2025_2991_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddc9/12179015/bf04f5e56897/12672_2025_2991_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddc9/12179015/6a60b1b6fbe1/12672_2025_2991_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddc9/12179015/669dce09fca8/12672_2025_2991_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddc9/12179015/32412dc0c88e/12672_2025_2991_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddc9/12179015/0545f4f5a7a1/12672_2025_2991_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddc9/12179015/82fb6c6743b2/12672_2025_2991_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddc9/12179015/147aa841543f/12672_2025_2991_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddc9/12179015/22be81cae3cb/12672_2025_2991_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddc9/12179015/bf04f5e56897/12672_2025_2991_Fig8_HTML.jpg

相似文献

1
Prognostic related signature predicts the benefits of immunotherapy for kidney renal clear cell carcinoma.预后相关特征预测免疫疗法对肾透明细胞癌的疗效。
Discov Oncol. 2025 Jun 19;16(1):1153. doi: 10.1007/s12672-025-02991-5.
2
Construction and validation of a prognostic model for glioma: an analysis based on mismatch repair-related genes and their correlation with clinicopathological features.胶质瘤预后模型的构建与验证:基于错配修复相关基因及其与临床病理特征相关性的分析
Transl Cancer Res. 2025 May 30;14(5):2690-2706. doi: 10.21037/tcr-24-2045. Epub 2025 May 9.
3
Identification and functional analysis of as a biomarker associated with immune-related genes in pediatric acute myeloid leukemia.作为儿童急性髓系白血病中与免疫相关基因相关的生物标志物的鉴定及功能分析。
Transl Cancer Res. 2025 May 30;14(5):2858-2873. doi: 10.21037/tcr-24-1595. Epub 2025 May 23.
4
Integrating multi-omics data to optimize immunotherapy in endometrial cancer: a comprehensive study.整合多组学数据以优化子宫内膜癌的免疫治疗:一项综合研究。
Discov Oncol. 2025 Jun 20;16(1):1161. doi: 10.1007/s12672-025-02978-2.
5
Cellular hierarchy framework based on single-cell and bulk RNA sequencing reveals fatty acid metabolic biomarker MYDGF as a therapeutic target for ccRCC.基于单细胞和批量RNA测序的细胞层级框架揭示脂肪酸代谢生物标志物MYDGF作为ccRCC的治疗靶点。
Front Immunol. 2025 Jun 5;16:1615601. doi: 10.3389/fimmu.2025.1615601. eCollection 2025.
6
Identifying a prognostic signature for clear cell renal cell carcinoma: the convergence of single-cell and bulk sequencing with machine learning.确定透明细胞肾细胞癌的预后特征:单细胞测序、批量测序与机器学习的融合
Front Cell Dev Biol. 2025 Jun 4;13:1560095. doi: 10.3389/fcell.2025.1560095. eCollection 2025.
7
Migrasome-related lncRNAs predict prognosis and immune response of clear cell renal cell carcinoma.与迁移小体相关的长链非编码RNA预测透明细胞肾细胞癌的预后和免疫反应。
Transl Androl Urol. 2025 May 30;14(5):1214-1229. doi: 10.21037/tau-2024-728. Epub 2025 May 27.
8
The impact of de novo lipogenesis on predicting survival and clinical therapy: an exploration based on a multigene prognostic model in hepatocellular carcinoma.从头脂肪生成对预测生存和临床治疗的影响:基于肝细胞癌多基因预后模型的探索
J Transl Med. 2025 Jun 18;23(1):679. doi: 10.1186/s12967-025-06704-y.
9
Identification of DCAF5 as a novel cancer prognostic and immunotherapy biomarker through pan-cancer analysis and renal clear cell carcinoma clinical data validation.通过泛癌分析和肾透明细胞癌临床数据验证,鉴定DCAF5作为一种新型癌症预后和免疫治疗生物标志物。
Discov Oncol. 2025 Jun 16;16(1):1119. doi: 10.1007/s12672-025-02974-6.
10
Unraveling the interconnectedness: A network-based study of type 2 diabetes and its comorbidities.揭示相互关联性:一项基于网络的2型糖尿病及其合并症研究
Comput Biol Med. 2025 Aug;194:110542. doi: 10.1016/j.compbiomed.2025.110542. Epub 2025 Jun 9.

本文引用的文献

1
Identification of Pathologic Grading-Related Genes Associated with Kidney Renal Clear Cell Carcinoma.鉴定与肾透明细胞癌病理分级相关的基因。
J Immunol Res. 2022 Jul 30;2022:2818777. doi: 10.1155/2022/2818777. eCollection 2022.
2
Expression of T-Cell Exhaustion Molecules and Human Endogenous Retroviruses as Predictive Biomarkers for Response to Nivolumab in Metastatic Clear Cell Renal Cell Carcinoma.T 细胞耗竭分子和人类内源性逆转录病毒的表达作为转移性透明细胞肾细胞癌对纳武利尤单抗反应的预测生物标志物。
Clin Cancer Res. 2021 Mar 1;27(5):1371-1380. doi: 10.1158/1078-0432.CCR-20-3084. Epub 2020 Nov 20.
3
Abnormal expression and prognostic significance of EPB41L1 in kidney renal clear cell carcinoma based on data mining.
基于数据挖掘的EPB41L1在肾透明细胞癌中的异常表达及预后意义
Cancer Cell Int. 2020 Jul 30;20:356. doi: 10.1186/s12935-020-01449-8. eCollection 2020.
4
Systemic therapy in the management of localized and locally advanced renal cell carcinoma: Current state and future perspectives.局部和局部进展性肾细胞癌的系统治疗:现状与未来展望。
Int J Urol. 2019 May;26(5):532-542. doi: 10.1111/iju.13943. Epub 2019 Apr 3.
5
irRECIST for the Evaluation of Candidate Biomarkers of Response to Nivolumab in Metastatic Clear Cell Renal Cell Carcinoma: Analysis of a Phase II Prospective Clinical Trial.irRECIST 用于评估纳武利尤单抗治疗转移性透明细胞肾细胞癌候选生物标志物反应:一项 II 期前瞻性临床试验分析。
Clin Cancer Res. 2019 Apr 1;25(7):2174-2184. doi: 10.1158/1078-0432.CCR-18-3206. Epub 2019 Jan 22.
6
Epidemiology of Renal Cell Carcinoma.肾细胞癌的流行病学。
Eur Urol. 2019 Jan;75(1):74-84. doi: 10.1016/j.eururo.2018.08.036. Epub 2018 Sep 19.
7
Identification of key genes and pathways in human clear cell renal cell carcinoma (ccRCC) by co-expression analysis.通过共表达分析鉴定人透明细胞肾细胞癌(ccRCC)中的关键基因和通路。
Int J Biol Sci. 2018 Feb 12;14(3):266-279. doi: 10.7150/ijbs.23574. eCollection 2018.
8
Co-expression network analysis identified six hub genes in association with metastasis risk and prognosis in hepatocellular carcinoma.共表达网络分析确定了六个与肝细胞癌转移风险和预后相关的枢纽基因。
Oncotarget. 2017 Jul 25;8(30):48948-48958. doi: 10.18632/oncotarget.16896.
9
Identifying biomarkers of papillary renal cell carcinoma associated with pathological stage by weighted gene co-expression network analysis.通过加权基因共表达网络分析鉴定与病理分期相关的乳头状肾细胞癌生物标志物。
Oncotarget. 2017 Apr 25;8(17):27904-27914. doi: 10.18632/oncotarget.15842.
10
Robust enumeration of cell subsets from tissue expression profiles.从组织表达谱中可靠地枚举细胞亚群。
Nat Methods. 2015 May;12(5):453-7. doi: 10.1038/nmeth.3337. Epub 2015 Mar 30.